Back to All News
Imperagen News
AI in Biotech / Drug Discovery3 articles
Latest news, updates, and announcements from Imperagen.
GeneralMay 26, 2026
Imperagen appoints Guy Levy-Yurista as CEO after £5M seed round for AI enzyme engineering.
Imperagen appoints Guy Levy-Yurista as CEO after £5M seed round for AI enzyme engineering. Manchester-based techbio company Imperagen has appointed Guy Levy-Yurista as CEO following a £5 million (~$6....
FundingMay 21, 2026
Imperagen, a Manchester-based BioTech spin-out from the University of Manchester, has closed €5.8 mi...
Imperagen, a Manchester-based BioTech spin-out from the University of Manchester, has closed €5.8 million (£5 million) in Seed funding to accelerate R&D, expand wet lab capacity, and build go-to-marke...
FundingMay 21, 2026
Imperagen Raises £5M Seed for AI-Driven Enzyme Engineering Platform
Imperagen Raises £5M Seed for AI-Driven Enzyme Engineering Platform Manchester-based techbio startup Imperagen has closed a £5 million seed round led by PXN Ventures, with participation from existing...